Physician profile
James E Craigie
NPI 1144225228
$4,791.58
in general payments reported to CMS, 2019-2025
13 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,961 · 2020: $368 · 2021: $734 · 2022: $345 · 2023: $233 · 2024: $589 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,009.39 | 2019-2023 | Avance Nerve Graft |
| Mentor Worldwide LLC | $1,482.73 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $405.49 | 2021-2025 | |
| Allergan, INC. | $235.75 | 2019-2021 | |
| Sanara Medtech INC. | $212.08 | 2025 | Celleraterx |
| Integra Lifesciences Corporation | $130.82 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Medtronic, INC. | $116.84 | 2024 | Plasmablade(Tm) |
| Somavac Medical Solutions, INC. | $75.00 | 2022 | |
| Abbott Laboratories | $48.62 | 2019 | |
| Baxter Healthcare | $24.28 | 2019 | |
| Sientra, INC. | $21.84 | 2022 | |
| Solventum Corporation | $16.75 | 2025 | Activ.A.C. |
| Innovation Technologies INC | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Craigie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.